GOLDMAN SACHS GROUP INC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$15,038,633
+187.5%
865,782
+133.0%
0.00%
+200.0%
Q2 2023$5,230,973
+15.2%
371,518
-11.9%
0.00%0.0%
Q1 2023$4,539,999
-70.2%
421,933
-58.5%
0.00%
-66.7%
Q4 2022$15,218,302
+30.9%
1,015,908
+12.2%
0.00%0.0%
Q3 2022$11,624,000
+89.2%
905,268
+42.8%
0.00%
+200.0%
Q2 2022$6,143,000
-34.0%
633,904
-32.3%
0.00%
-50.0%
Q1 2022$9,310,000
+36.6%
936,604
+61.7%
0.00%
+100.0%
Q4 2021$6,817,000
+22.3%
579,217
+18.3%
0.00%0.0%
Q3 2021$5,576,000
-5.5%
489,573
+15.5%
0.00%0.0%
Q2 2021$5,902,000
-25.0%
423,696
-0.3%
0.00%
-50.0%
Q1 2021$7,869,000
-20.4%
425,161
-24.0%
0.00%
-33.3%
Q4 2020$9,881,000
+464.0%
559,210
+389.0%
0.00%
Q3 2020$1,752,000
-18.3%
114,357
+35.9%
0.00%
-100.0%
Q2 2020$2,144,000
+510.8%
84,128
+270.7%
0.00%
Q1 2020$351,000
+134.0%
22,697
+67.6%
0.00%
Q4 2019$150,000
-69.9%
13,543
-76.9%
0.00%
Q3 2019$499,000
+162.6%
58,634
+317.8%
0.00%
Q2 2019$190,000
-39.7%
14,033
-19.7%
0.00%
Q1 2019$315,000
-79.8%
17,469
-80.6%
0.00%
Q2 2018$1,563,00090,0900.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders